TejalAmarPatelMD

PubMed

• 1 citations
  A Deep Learning Decision Support Tool to Improve Risk Stratification and Reduce Unnecessary Biopsies in BI-RADS 4 Mammograms.
  Ezeana, C., He, T., Patel, T., Kaklamani, V., Elmi, M., Brigmon, E., Otto, P., Kist, K., Speck, H., Wang, L., Ensor, J., Shih, Y., Kim, B., Pan, I., Cohen, A., Kelley,...> ;Radiology. Artificial Intelligence. 2023 Nov 1
• 3 citations
  A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer.
  Kai Sun, Yitian Xu, Licheng Zhang, Polly Niravath, Jorge Darcourt, Tejal Patel, Bin S Teh, Andrew M Farach, Carlo Guerrero, Sunil Mathur, Mark A Sultenfuss, Nakul Gupt...> ;Clinical Cancer Research. 2022 Oct 14
• 1 citations
  Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases.
  Akshjot Puri, Charisma Mylavarapu, Jiaqiong Xu, Tejal A Patel, Bin S Teh, Ivo Tremont-Lukats, Jenny C Chang, Polly Niravath> ;Breast Cancer Research and Treatment. 2022 Jun 1
• 39 citations
  A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.
  Andrew W Chung, Kartik Anand, Ann C Anselme, Alfred A Chan, Nakul Gupta, Luz A Venta, Mary R Schwartz, Wei Qian, Yitian Xu, Licheng Zhang, John Kuhn, Tejal Patel, Ange...> ;Science Translational Medicine. 2021 Dec 15
• 19 citations
  A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractor...
  Kartik Anand, Polly A. Niravath, Tejal Patel, Joe Ensor, Angel Rodriguez, Toniva Boone, Stephen T. C. Wong, Jenny C. Chang> ;Clinical Breast Cancer. 2021 Jun 1
• 5 citations
  ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
  Emre Koca, Polly A. Niravath, Joe Ensor, Tejal Patel, Xiaoxian Li, Pej Hemati, Helen Wong, Wei Qian, Toniva Boone, Jing Zhao, Priya V. Ramshesh, Adam L. Cohen, Asha Mu...> ;Breast Cancer Research and Treatment. 2021 Apr 15
• 7 citations
  Medical Complications and Prognostic Factors for Medically Unstable Conditions During Acute Inpatient Cancer Rehabilitation.
  Jegy M. Tennison, Brian C. Fricke, Jack B. Fu, Tejal Patel, Minxing Chen, Eduardo Bruera> ;JCO Oncology Practice. 2021 Mar 8
• 4 citations
  Measuring Ovarian Escape in Premenopausal Estrogen Receptor-Positive Breast Cancer Patients on Ovarian Suppression Therapy
  Ethan Burns, Emre Koca, Jiaqiong Xu, Edward T. McLean, Rosetta Lee, Tejal Patel, Jenny C. Chang, Polly A. Niravath> ;The Oncologist. 2021 Jun 1
• 14 citations
  Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy.
  Kartik Anand, Tejal Patel, Polly A. Niravath, Angel Rodriguez, Jorge Darcourt, Anna Belcheva, Toniva Boone, Joe Ensor, Jenny C. Chang> ;Scientific Reports. 2021 Jan 8
• 16 citations
  Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
  Kurt A. Jaeckle, Jesse G. Dixon, Stephen Keith Anderson, Alvaro Moreno-Aspitia, Gerardo Colon-Otero, Kathy Hebenstreit, Tejal Patel, Samarth L. Reddy, Edith A. Perez> ;Cancer Medicine. 2020 Sep 3
• 6 citations
  Metastatic triple-negative breast cancer: Established and emerging treatments.
  Akshjot Puri, Tejaswini P. Reddy, Tejal Patel, Jenny C. Chang> ;The Breast Journal. 2020 Jun 23
• 20 citations
  Prognosis of lymphotropic invasive micropapillary breast carcinoma analyzed by using data from the National Cancer Database.
  Gary D. Lewis, Yan Xing, Waqar Haque, Tejal Patel, Mary R. Schwartz, Albert C. Chen, Andrew M. Farach, Sandra S. Hatch, E. Brian Butler, Jenny C. Chang, Bin S. Teh> ;Cancer Communications. 2019 Oct 21
• 28 citations
  A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-...
  Tejal Patel, Joe Ensor, Sarah L. Creamer, Toniva Boone, Angel Rodriguez, Polly A. Niravath, Jorge Darcourt, Jane L. Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Rober...> ;Breast Cancer Research. 2019 Sep 2
• 18 citations
  The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast.
  Gary D. Lewis, Yan Xing, Waqar Haque, Tejal Patel, Mary R. Schwartz, Albert C. Chen, Andrew M. Farach, Sandra S. Hatch, E. Brian Butler, Jenny C. Chang, Bin S. Teh> ;The Breast Journal. 2019 Jul 18
• 16 citations
  A Deep Learning-Based Decision Support Tool for Precision Risk Assessment of Breast Cancer.
  Tiancheng He, Mamta Puppala, Chika F. Ezeana, Yan siang Huang, Ping hsuan Chou, Xiaohui Yu, Shenyi Chen, Lin Wang, Zheng Yin, Rebecca L. Danforth, Joe Ensor, Jenny C. ...> ;JCO Clinical Cancer Informatics. 2019 May 29
• 29 citations
  Enhanced dermatologic toxicity following concurrent treatment with palbociclib and radiation therapy: A case report
  Jay A. Messer, Ekim Ekinci, Tejal Patel, Bin S. Teh> ;Reports of Practical Oncology and Radiotherapy. 2019 May 1
• 15 citations
  A Behavior-Modification, Clinical-Grade Mobile Application to Improve Breast Cancer Survivors' Accountability and Health Outcomes.
  Renee E. Stubbins, Tiancheng He, Xiaohui Yu, Mamta Puppala, Chika F. Ezeana, Shenyi Chen, Miguel Valdivia y Alvarado, Joe Ensor, Angel Rodriguez, Polly A. Niravath, Je...> ;JCO Clinical Cancer Informatics. 2018 Nov 30
• 32 citations
  Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods
  Tejal Patel, Mamta Puppala, Richard Ogunti, Joe Ensor, Tiancheng He, Jitesh B. Shewale, Donna P. Ankerst, Virginia G. Kaklamani, Angel Rodriguez, Stephen T. C. Wong, J...> ;Cancer. 2017 Jan 1
• 45 citations
  Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients
  Diana H. Liang, Joe Ensor, Zhe Bin Liu, Asmita Patel, Tejal Patel, Jenny C. Chang, Angel Rodriguez> ;Breast Cancer Research and Treatment. 2016 Jan 1
• 11 citations
  Dual HER2 blockade: preclinical and clinical data
  Tejal Patel, Bhuvanesh Dave, Angel Rodriguez, Jenny C. Chang, Edith A. Perez, Gerardo Colon-Otero> ;Breast Cancer Research. 2014 Jul 31
• Erratum: Dual HER2 blockade: preclinical and clinical data.
  Tejal Patel, Bhuvanesh Dave, Angel Rodriguez, Jenny C. Chang, Edith A. Perez, Gerardo Colon-Otero> ;Breast Cancer Research. 2014 Nov 6
• 2 citations
  Chemical Castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination
  Luis M Vence, Chiyu Wang, Himabindu Pappu, Ryan E. Anson, Tejal Patel, Priscilla W. Miller, Roland L. Bassett, Gregory Lizée, Willem W. Overwijk, Krishna V. Komanduri,...> ;Journal of Immunotherapy. 2013 May 1
• 14 citations
  RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer
  Alvaro Moreno-Aspitia, Amylou C. Dueck, Ismael Ghanem-Cañete, Tejal Patel, Shaker R. Dakhil, David B. Johnson, Sandra X. Franco, S. P. Kahanic, Gerardo Colon-Otero, Ka...> ;Breast Cancer Research and Treatment. 2013 Mar 12
• 48 citations
  Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy
  Lorenzo Cohen, Patricia A. Parker, Luis M Vence, Cheryln Savary, Diane Kentor, Curtis A. Pettaway, Richard J. Babaian, Louis L. Pisters, Brian J. Miles, Qi Wei, Leslie...> ;Psychosomatic Medicine. 2011 Apr 1
• SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer.
  Mayer EL, Dhakil S, Patel T, Sundaram S, Fabian C, Kozloff M, Qamar R, Volterra F, Parmar H, Samant M, Burstein HJ> ;Ann. Oncol.. 2010-12-01
• Join now to see all